This is a news story, published by ScienceDaily, that relates primarily to Boston Medical Center news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
sickle cell disease patients. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest sickle cell disease pathology news, hemoglobin molecules news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
sickle cell diseaseScienceDaily
•
77% Informative
New small molecule could treat sickle cell disease in adults that don't respond to hydroxyurea, alone.
Researchers at Boston Medical Center found a small molecule that increases fetal hemoglobin production in human blood stem cells and leads to fewer sickled red blood cells.
The findings provide proof of principle for developing more effective therapeutics.
VR Score
85
Informative language
90
Neutral language
60
Article tone
formal
Language
English
Language complexity
65
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links